Biological markers predictive of anticancer response to insulin-like growth factor-1 receptor kinase inhibitors

Details for Australian Patent Application No. 2006292278 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Haley, John D.

Agent Spruson & Ferguson

Pub. Number AU-B-2006292278

PCT Pub. Number WO2007/035744

Priority 60/718,643 20.09.05 US

Filing date 19 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 8 March 2012

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035744 Priority application(s): WO2007/035744

8 March 2012 Application Accepted

  Published as AU-B-2006292278

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292280-Specimen enclosure apparatus and containers and closure devices for the same

2006292277-Downloadable filters for a visual prosthesis